• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> KRAS Polyclonal Antibody / K-Ras Protein Antibody

KRAS Polyclonal Antibody / K-Ras Protein Antibody (F44713)

  Catalog No Formulation Size Price (USD)  
Image F44713-0.2ML In 1X PBS, pH 7.4, with 0.09% sodium azide 0.2 ml 439
Image
F44713-0.05ML In 1X PBS, pH 7.4, with 0.09% sodium azide 0.05 ml 205
Bulk quote request
KRAS Polyclonal Antibody WB in Human, Mouse, and Rat Cell Lysates. Western blot analysis of human HeLa (lane 1), human 293/T17 (lane 2), mouse C2C12 (lane 3), rat C6 (lane 4), human HT-29 (lane 5), and rat PC-12 (lane 6) cell lysates using the K-Ras Protein Antibody at a dilution of 1:500. A prominent band is detected at approximately 21-23 kDa in all six samples, consistent with the expected molecular weight of KRAS (20-25 kDa).
Western blot testing of 1) human 293T/17, 2) mouse C2C12, 3) human HeLa, 4) human HT-29, 5) human K562, 6) rat PC-12 and 7) human Ramos cell lysate with KRAS antibody at 1:2000. Expected molecular weight: 20-25 kDa.
KRAS antibody western blot analysis in mouse NIH3T3 lysate. Predicted molecular weight: 20-25 kDa.
KRAS Polyclonal Antibody IF in Human WiDr Cells. Confocal immunofluorescence analysis of human WiDr cells using the K-Ras Protein Antibody, detected with Alexa Fluor 488-conjugated goat anti-rabbit IgG (green). KRAS-associated fluorescence is observed throughout the cytoplasm, including peripheral regions of the cells. Actin filaments were labeled with Alexa Fluor 555-conjugated phalloidin (red), and nuclei were counterstained with DAPI (blue).
KRAS Polyclonal Antibody FACS in Human HeLa Cells. Flow cytometry analysis of human HeLa cells using the K-Ras Protein Antibody and an FITC-conjugated goat anti-rabbit secondary antibody. The antibody-stained population (right histogram, green) exhibits a substantial rightward fluorescence shift compared with the negative control (left histogram, blue), indicating KRAS-associated immunoreactivity.
Species Reactivity Human, Mouse, Rat
Format Antigen affinity purified
Host Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Purity Antigen affinity
UniProt P01116
Applications Western blot: 1:500-1:2000
Immunofluorescence: 1:10-1:50
Flow Cytometry: 1:10-1:50
Limitations This KRAS Polyclonal Antibody / K-Ras Protein Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

KRAS Polyclonal Antibody / K-Ras Protein Antibody targets KRAS, a member of the RAS family of small guanosine triphosphatases that regulate intracellular signaling in response to extracellular growth factors. KRAS is encoded by the Kirsten rat sarcoma viral oncogene homolog and functions as a molecular switch, alternating between active GTP-bound and inactive GDP-bound states. Alongside HRAS and NRAS, KRAS participates in signaling pathways that influence cell proliferation, differentiation, survival, and metabolic adaptation. Its activity is tightly regulated to ensure that growth-promoting signals are transmitted for appropriate durations.

Activation of KRAS commonly occurs downstream of receptor tyrosine kinases, including members of the epidermal growth factor receptor family. Receptor stimulation recruits adaptor proteins and guanine nucleotide exchange factors such as SOS1, which facilitate the release of GDP and binding of GTP. Activated KRAS interacts with downstream effectors, including RAF kinases, to initiate the RAF-MEK-ERK signaling cascade. KRAS can also engage PI3K and other effector proteins, connecting receptor activation to pathways involved in cellular metabolism, cytoskeletal organization, and survival. GTPase-activating proteins accelerate GTP hydrolysis and help terminate these signaling responses.

The KRAS gene produces two principal splice variants, KRAS4A and KRAS4B, which share most of their amino acid sequences but differ in their C-terminal membrane-targeting regions. These differences influence intracellular localization, membrane interactions, and regulatory mechanisms. Post-translational processing, including farnesylation, is essential for normal membrane association and signaling activity. The relative expression of KRAS isoforms can vary among tissues and cellular conditions, potentially influencing their contributions to specific signaling pathways.

Oncogenic KRAS mutations frequently affect residues involved in GTP hydrolysis and regulatory protein interactions. Alterations at codons 12, 13, and 61 can promote sustained signaling through pathways that support uncontrolled proliferation. KRAS mutations are particularly common in pancreatic ductal adenocarcinoma, colorectal cancer, and lung adenocarcinoma. Their biological effects depend on mutation identity, tissue context, and cooperating genetic alterations. Research into KRAS signaling has also expanded through the development of mutation-selective inhibitors and investigations of acquired therapeutic resistance. This KRAS Polyclonal Antibody provides an additional reagent for examining KRAS expression and its relationship to intracellular signaling, tumor biology, and the molecular mechanisms of oncogenic transformation.

Explore our KRAS Antibody for additional research into Kirsten Ras protein expression and RAS-dependent signaling, with Western blot validation using A549 wild-type and KRAS knockout cell lysates.

Application Notes

Titration of the KRAS Polyclonal Antibody / K-Ras Protein Antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Immunogen

A portion of amino acids 146-174 from the human protein was used as the immunogen for this KRAS Polyclonal Antibody.

Storage

Aliquot the KRAS Polyclonal Antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Alternate Names

Kirsten Ras antibody, Kirsten rat sarcoma viral oncogene homolog antibody, KRAS proto-oncogene antibody, K-Ras GTPase antibody, KRAS p21 antibody, Kirsten Ras protein antibody, KRAS small GTPase antibody, KRAS2 antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.